Marijuana Tied to Increased Risk for LUTS Medications in BPH
Marijuana use also linked to worse overall semen parameters due to induction of oxidative stress
Benign Prostatic Hyperplasia
BPH Meds Found to Delay Prostate Cancer Diagnosis
Men treated with 5-alpha reductase inhibitors were diagnosed with prostate cancer 2 years later than men not using these drugs.
Water Vapor Therapy for BPH Shows Good Short-Term Efficacy
By 3 and 6 months, flow rate, post void residual, IPSS, quality of life, and prostate volume improved in patients treated with the Rezum system, which uses convective heating to ablate prostate tissue.
Aquablation Effective for BPH Despite Large Prostates
Men with larger vs smaller prostate gland sizes treated with Aquablation experienced similar improvement in International Prostate Symptom Score.
Risk for T2DM Increased With Use of 5α-Reductase Inhibitors
Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia
BPH Prostatic Artery Embolization Facilitated With MR Angiography
Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.
Aquablation, TURP Outcomes Similar at 1 Year
Randomized trial reveals no significant difference between Aquablation and TURP in improvements in lower urinary tract symptoms, peak urinary flow, and post-void residual volume.
Seminal Vesicle Problems May Be a PAE Complication
Seminal vesicle abnormalities may beamong the complications of prostaticartery embolization (PAE), according toa new report published in BMC Urology. In a review of 139 patients whounderwent PAE for benign prostatehyperplasia,Jin Long Zhang, MD, ofNan Kai University in Tianjin, China, andcolleagues identified 9 (6.5%) who hadseminal vesicle abnormalities detectedby magnetic resonance imaging. Theabnormalities included subacute hemorrhagein…
Desmopressin Effectively Treats Nocturia in BPH
Nocturia improved 43% in patients receiving oral desmopressin alone and 64.3% in those receiving desmopressin and an alpha-blocker.
Most Transient SUI After HoLEP Resolves Within 6 Weeks
Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.
Next post in ICS 2018 Coverage
